Patent US5676977A is for AIDS, patent US8835624B1 is for H1N1, patents US7897744B2 and US8506968B2 are for SARS
FULL CLAIM: Patent US5676977A is for AIDS, patent US8835624B1 is for H1N1, patents US20120251502A1 and CA2741523A1 are for Ebola, patent US8124101B2 is for swine flu, patent ATCC VR-84 is for Zika, patents US7897744B2 and US8506968B2 are for SARS, patent US10130701B2 is for coronavirus [...] This attribution is also inaccurate. This patent isn’t for the H1N1 influenza virus, which causes swine flu, but for an aptamer that binds specifically to the H1N1 influenza virus and ways of using the aptamer. It was filed in 2014 by researchers at the National Tsing Hua University in Taiwan. An aptamer is a short strand of nucleic acid (DNA or RNA) that can bind to proteins on cells and viruses, like antibodies. This feature makes aptamers potentially useful for discovery, diagnostic, and therapeutic purposes[1-3]. [...] The first is a patent for the genomic sequence of the virus SARS-CoV-1, which causes severe acute respiratory syndrome (SARS). It’s not a patent for the virus itself. It was filed in 2004 by the Public Health Agency of Canada.